Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 22.73 as of Thursday, July 30, 2026.
Forward PE Ratio (22.73) = Close Price ($265.53) / Consensus Forward EPS ($11.68)
FORWARD PE RATIO
22.73
SECTOR MEDIAN · HEALTHCARE
19.43
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+16.98%
vs the sector median at left
Johnson & Johnson
Market Cap
$639.90B
Forward PE Ratio
22.73
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Johnson & Johnson (JNJ) | $639.90B | 22.73 |
| Pfizer Inc. (PFE)vs › | $143.34B | 8.54 |
| Merck & Co., Inc. (MRK)vs › | $322.04B | 47.02 |
| AbbVie Inc. (ABBV)vs › | $465.69B | N/A |
| Eli Lilly and Company (LLY)vs › | $1.14T | 34.45 |
| Bristol-Myers Squibb Company (BMY)vs › | $128.85B | 9.95 |
Trailing P/E
30.8
reported TTM EPS
Forward P/E
22.7
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $11.68 implies +35.3% EPS growth vs the reported trailing $8.63.
At today's $265.53 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-28 | $11.68 | $11.48 – $11.92 | 12 | 22.7x |
| 2027-12-28 | $12.88 | $12.32 – $13.62 | 12 | 20.6x |
| 2028-12-28 | $14.34 | $10.85 – $16.71 | 5 | 18.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
